Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 46, 735-739, February 1, 1986]
© 1986 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Erratum (v46,p3748)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carmichael, J.
Right arrow Articles by Wolf, C. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carmichael, J.
Right arrow Articles by Wolf, C. R.

Glutathione and Glutathione Transferase Levels in Mouse Granulocytes following Cyclophosphamide Administration1

James Carmichael2, David J. Adams3, John Ansell and C. Roland Wolf4

Imperial Cancer Research Fund, Laboratory of Molecular Pharmacology and Drug Metabolism, Department of Biochemistry, George Square [J. C., D. J. A., C. R. W.], and Department of Zoology, The King's Buildings [J. A.], University of Edinburgh, Edinburgh, United Kingdom

Following an initial depletion, glutathione and glutathione transferase levels are transiently increased in mouse bone marrow following the administration of a low dose of cyclophosphamide. Similar effects are observed on subsequent administration of the drug. The separation of various bone marrow populations on a fluorescence-activated cell sorter has shown that increase in glutathione and glutathione transferase levels are restricted to the granulocytic fraction. This may well provide an explanation for the protective effect of a low ‘priming’ dose of cyclophosphamide against a subsequent lethal dose. The changes in granulocytic glutathione and glutathione transferase levels can also be monitored in the peripheral circulation. The enhanced levels of glutathione in cells resulting from cytotoxic insult appear to be a general response of cells to cytotoxins and may be important in both antitumor therapy as well as the initiation of chemical toxicity and carcinogenicity.

1 The financial support of the Cancer Research Campaign, Grant No. SP 1610, is gratefully acknowledged.

2 Present address: National Cancer Institute, Naval Medical Oncology Branch, Bethesda, MD.

3 Present address: Department of Microbiology, University of Leeds, Leeds, LS2 9JT, United Kingdom.

4 To whom requests for reprints should be addressed.

Received 5/29/85. Revised 10/23/85. Accepted 10/24/85.




This article has been cited by other articles:


Home page
Cancer Res.Home page
G. J. Pass, D. Carrie, M. Boylan, S. Lorimore, E. Wright, B. Houston, C. J. Henderson, and C. R. Wolf
Role of Hepatic Cytochrome P450s in the Pharmacokinetics and Toxicity of Cyclophosphamide: Studies with the Hepatic Cytochrome P450 Reductase Null Mouse
Cancer Res., May 15, 2005; 65(10): 4211 - 4217.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1986 by the American Association for Cancer Research.